Growth Metrics

Mannkind (MNKD) Return on Equity (2011 - 2026)

Mannkind (MNKD) reported Return on Equity of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and up 2850.75% on a QoQ basis from 0.0% in Q4 2025.

Mannkind (MNKD) has 16 years of Return on Equity data on file, last reported at 0.01% in Q1 2026.

  • Quarterly Return on Equity rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Equity rose to 0.01% in Q1 2026 per MNKD's latest filing, from 0.0% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.01% in Q1 2026 and bottomed at 0.01% in Q3 2025.
  • The 5-year median for Return on Equity is 0.0% (2023), against an average of 0.0%.
  • The widest annual swing landed in 2025, when Return on Equity fell 1 bps; it then grew 1 bps in 2026.
  • Tracing MNKD's Return on Equity over 5 years: stood at 0.0% in 2022, then sank by 87 bps to 0.0% in 2023, then slumped by 499 bps to 0.0% in 2024, then surged by 90 bps to 0.0% in 2025, then surged by 2851 bps to 0.01% in 2026.
  • Per Business Quant, the three latest MNKD Return on Equity figures stand at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -0.04%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -0.01%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.00%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.00%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.01%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn 0.01%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.01%
Dec 31, 2025 0.00%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.01%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 0.00%
Mar 31, 2021 0.00%
Dec 31, 2020 0.00%
Sep 30, 2020 0.00%
Jun 30, 2020 0.00%
Mar 31, 2020 0.00%
Dec 31, 2019 0.00%
Sep 30, 2019 0.00%
Jun 30, 2019 0.00%
Mar 31, 2019 0.00%
Dec 31, 2018 0.00%
Sep 30, 2018 0.00%
Jun 30, 2018 0.00%
Mar 31, 2018 0.00%
Dec 31, 2017 0.00%
Sep 30, 2017 0.00%
Jun 30, 2017 -0.01%
Mar 31, 2017 -0.01%
Dec 31, 2016 -0.01%
Sep 30, 2016 -0.01%
Jun 30, 2016 0.00%
Mar 31, 2016 0.00%
Dec 31, 2015 0.00%
Sep 30, 2015 0.01%
Jun 30, 2015 0.01%
Mar 31, 2015 0.02%
Dec 31, 2014 0.03%
Sep 30, 2014 0.05%
Jun 30, 2014 0.16%
Mar 31, 2014 0.31%
Dec 31, 2013 0.02%
Sep 30, 2013 0.01%
Jun 30, 2013 0.01%
Mar 31, 2013 0.01%
Dec 31, 2012 0.01%
Sep 30, 2012 0.01%
Jun 30, 2012 0.01%
Mar 31, 2012 0.01%
Dec 31, 2011 0.01%
Sep 30, 2011 0.01%